Showing results (521-530 of 1,813) with videos related to

Sort By:
Pageof 182
Transplantation and Cellular Therapy|March 9, 2025
Best Practices in Gene Therapy for Sickle Cell Disease and Transfusion-dependent β-ThalassemiaHaydar Frangoul, Amanda Stults, Katie Bruce, et al.
Transplantation and Cellular Therapy|March 7, 2025
Efficacy of Pomalidomide on Motor Performance and Functional Abilities in Patients with Steroid Refractory Chronic Graft Versus Host Disease: A Randomized Clinical StudyJessica J Jorgensen, Galen O Joe, Rafael Jiménez-Silva, et al.
Transplantation and Cellular Therapy|April 4, 2025
High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical TransplantationChristopher C Dvorak, Soohee Cho, Gabriel Salinas Cisneros, et al.
Transplantation and Cellular Therapy|March 9, 2025
Temporal Evolution of Functional Immune Reconstitution after Allogeneic HSCTWilliam Mouton, Léa Aguilhon, Vincent Alcazer, et al.
Transplantation and Cellular Therapy|December 19, 2024
Incidence, Risk Factors, and Outcomes of BK Hemorrhagic Cystitis in Hematopoietic Stem Cell Transplantation From HLA-Matched and Haploidentical Donors With Post-Transplant CyclophosphamidePedro Chorão, Marta Villalba, Aitana Balaguer-Roselló, et al.
Transplantation and Cellular Therapy|December 19, 2024
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part I. Phases of Chronic GVHD, Supportive Care, and Systemic Therapy DiscontinuationNeel S Bhatt, Andrew C Harris, Lev Gorfinkel, et al.
Transplantation and Cellular Therapy|December 19, 2024
Health-Related Values Discussions with Patients Undergoing Allogeneic and Autologous Stem Cell Transplant: Feasibility and Acceptability of an Early Primary Palliative Care InterventionAbigail G Cohen, Christina Cho, Emily Patterson, et al.
Transplantation and Cellular Therapy|December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk GroupNikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
Transplantation and Cellular Therapy|November 27, 2024
Inconsistent Reporting and Definitions of Time-to-Event Endpoints in CAR T Clinical Trials: A ReviewConnor B Grady, Yimei Li, Shannon L Maude, et al.
Transplantation and Cellular Therapy|November 6, 2024
Novel Drug Combinations and Donor Lymphocyte Infusions Allow Prolonged Disease Control in Multiple Myeloma Patients Relapsing after Allogeneic TransplantationChiara Nozzoli, Martina Pucillo, Luisa Giaccone, et al.
Pageof 182